Parrish, AGray, AKredo, TMaartens, GReubenson, GCohen, KDe Waal, RBlockman, MNel, JRees, H2025-01-092025-01-092020-04-08Parrish A, Gray A, Kredo T, Maartens G, et al. Intravenous immunoglobin for COVID-19: evidence review of potential benefit and harm. South African National Department of Health, 2020.http://www.health.gov.za/wp-content/uploads/2020/12/Rapid-review-of-IV-Immunoglobulin-for-COVID-19_8April2020.pdfhttps://hdl.handle.net/11288/598082Immunoglobin therapy is the use of mixture antibodies to treat a number of health conditions.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/ImmunoglobinIntravenous ImmunoglobinImmunoglobin therapyAntibodyImmune systemBiologyIntravenous immunoglobin for COVID-19: Evidence review of potential benefit and harmTechnical Report